Insider Trading & Ownership of John P. Saharek

Location
San Diego, CA
Summary
The estimated net worth of John P. Saharek is at least $10,791,989 dollars as of 07 Apr 2025. John P. Saharek is the CEO & President, ImprimisRx of HARROW, INC. and owns shares of HARROW, INC. (HROW) stock worth about $10.79M.
Signature
/s/ John P. Saharek
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow John P. Saharek and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • John P. Saharek has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $10,791,989.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: HARROW, INC. ($10,791,989).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of John P. Saharek

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
HROW HARROW, INC. CEO & President, ImprimisRx $10,791,989 03 Apr 2025

Insider Transactions Reported by John P. Saharek:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .